Stem Cell Assays Market

Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany) and Danaher (US) are the Prominent Players in the Stem Cell Assays Market

The stem cell assays market is projected to reach USD 4.5 Billion by 2027 from USD 1.9 Billion in 2022, at a CAGR of 17.7% during the forecast period. Growth in the stem cell assays market can be attributed to factors such as the increasing awareness about the therapeutic potency of stem cells, increasing funding for stem cell research, rising demand for cell-based assays in drug discovery, collaborations and agreements among market players.

The global stem cell assays market is highly competitive. The prominent players operating in this market include Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Danaher (US), Becton, Dickinson and Company (US), Bio-Rad Laboratories (US), PerkinElmer (US), Agilent Technologies (US), Promega Corporation (US), Cell Biolabs (US), Miltenyi Biotec (Germany), STEMCELL Technologies (Canada), Bio-Techne Corp6oration (US), FUJIFILM Holdings Corporation (Japan), Charles River Laboratories (US), HemoGenix Inc. (US), Lonza Group (Switzerland), Takara Bio Inc. (Japan), Creative Bioarray (US), AAT Bioquest, Inc. (US), BPS Bioscience, Inc. (US), Enzo Biochem (US), PromoCell GmbH (Germany), Biotium (US), Geno Technology (US), Abcam plc (UK), and ReachBio Research Labs (US). Product launch, partnerships, collaborations and geographic expansion are the key growth strategies undertaken by these companies to maintain their positions in the market.

To know about the assumptions considered for the study download the pdf brochure

Thermo Fisher Scientific Inc.  

In 2021, Thermo Fisher Scientific Inc. accounted for the largest market share in the stem cell assays market. The company’s leading position can be attributed to its strong brand image, robust product portfolio, and strong focus on strengthening its position by launching new products in the market.

Merck KGaA

Merck KGaA held the second position in the stem cell assays market in 2021. Merck has expanded its position as the most profitable technology and solutions supplier in the stem cell assays market by offering a wide product portfolio for biotech & pharmaceutical companies and for the advancement of cell and gene therapy.


Danaher is a prominent player in the stem cell assays market. The company offers a wide range of products in this market. To maintain its position in the market, the company focuses on organic as well as inorganic growth strategies such as product launches and acquisitions. Recent launches include ImageXpress Micro Confocal High-Content Imaging System (2020), FLIPR Penta High-Throughput Cellular Screening System (2019), and ImageXpress Pico Automated Cell Imaging System (2018).

Related Reports:

Stem Cell Assays Market by Type (Viability, Proliferation, Differentiation, Apoptosis), Cell Type (Mesenchymal, iPSCs, HSCs, hESCs), Product & Service (Instrument), Application (Regenerative Medicine, Clinical Research), End User - Global Forecast to 2027

Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]

Stem Cell Assays Market Size,  Share & Growth Report
Report Code
BT 4628
RI Published ON
Choose License Type

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
©2024 MarketsandMarkets Research Private Ltd. All rights reserved Protection Status